Track topics on Twitter Track topics that are important to you
72 New Bond Street
Phone: 44 (0)870 240 5978
London, UK, 16th October 2017 / Sciad Newswire / BioMoti, Pharmidex and Queen Mary University of London (QMUL) have been awarded a grant of £662,222 by the UK’s innovation agency, Innovate UK.
Pharmidex is a solution provider in brain medicines research. Headquartered in London, we specialise in predicting and assessing the ability of compounds to cross the permeability barrier betweenblood...
We have published hundreds of Pharmidex news stories on BioPortfolio along with dozens of Pharmidex Clinical Trials and PubMed Articles about Pharmidex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmidex Companies in our database. You can also find out about relevant Pharmidex Drugs and Medications on this site too.
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...